News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘ChildhoodCancer’ clear

  • Common variations in four genes related to brain inflammation or cells' response to damage from oxidation may contribute to the problems with memory, learning and other cognitive functions seen in children treated for acute lymphoblastic leukemia (ALL), according to research presented at the annual American Society of Hematology annual meeting in San Francisco.

Tags: ChildhoodCancer, Survivorship, Leukemia

  • David Pellman, MD, a pediatric oncologist at Dana-Farber and Children's Hospital Boston, is one of 56 scientists just selected as an investigator of the Howard Hughes Medical Institute, a non-profit medical research organization that ranks as one of the nation's largest philanthropies.

Tags: BasicResearch, ChildhoodCancer

  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center has joined a Memorial Sloan Kettering clinical trial of immunotherapy for children with relapsed or treatment-resistant acute lymphoblastic leukemia. Dana-Farber/Boston Children’s is the only site in New England to offer this breakthrough experimental approach that triggers a patient's immune system to attack cancer cells.

Tags: ChildhoodCancer, Immunotherapy

  • Dana-Farber/Children's Hospital Cancer Center physicians and nurses are collaborating to create an Egypt-based fellowship training program in pediatric oncology.

Tags: ChildhoodCancer, Partnerships

  • David G. Nathan, MD, president emeritus of Dana-Farber Cancer Institute and physician-in-chief emeritus of Boston Children's Hospital, was honored as the inaugural recipient of the Boston Children’s Hospital Lifetime Impact Award at the hospital’s second Annual Global Pediatric Innovation Summit, Taking on Tomorrow (#PedInno14).

Tags: ChildhoodCancer, Honors

  • When the eye cancer retinoblastoma is diagnosed in racial and ethnic minority children whose families don't have private health insurance, it often takes a more invasive course than in other children, probably because of delays in diagnosis, according to researchers at Dana-Farber/Children's Hospital Cancer Center in Boston.

Tags: ChildhoodCancer, Disparities

  • New findings led by researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center show informing parents about their child's cancer prognosis – even when the prognosis is less than favorable – is much more likely to give parents peace of mind and hope rather than increase their anxiety or cause them to become depressed.

Tags: ChildhoodCancer

  • Disparities in outcomes for children with retinoblastoma — a rare eye tumor usually discovered in routine pediatric check-ups — suggest unequal access to primary care, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center report in a study published in the journal JAMA Pediatrics. Although virtually all the children in the study survived, Hispanic children and children who lived in disadvantaged areas were more likely to lose an eye due to late diagnosis.

Tags: ChildhoodCancer, ChildhoodCancerSurvivorship, Disparities

  • A national drug shortage has been linked to a higher rate of relapse among Hodgkin lymphoma patients enrolled in a national pediatric clinical trial, report researchers involved in the study.

Tags: chemotherapy, ChildhoodCancer, Lymphoma

  • Researchers at Dana-Farber and Children's Hospital Boston have shown that changes in the structure of DNA are responsible for hard-to-treat MLL leukemia – and that it's possible to reverse this process.

Tags: BasicResearch, ChildhoodCancer

Showing 11-20 of 51 items